Breeksema, Joost J.

Reviewing the Potential of Psychedelics for the Treatment of PTSD

Krediet, E., Bostoen, T., Breeksema, J., van Schagen, A., Passie, T., & Vermetten, E. (2020) · International Journal of Neuropsychopharmacology

Psychedelics and Drug StudiesPosttraumatic Stress Disorder Research

Cited by 260

Psychedelic treatments for psychiatric disorders: a systematic review and thematic synthesis of patient experiences in qualitative studies

Breeksema, J. J., Niemeijer, A. R., Krediet, E., Vermetten, E., & Schoevers, R. A. (2020) · CNS Drugs

Psychedelics and Drug StudiesPsychotherapy Techniques and Applications

Cited by 224

Adverse events in clinical treatments with serotonergic psychedelics and MDMA: a mixed-methods systematic review.

Breeksema, J. J., Kuin, B. W., Kamphuis, J., van den Brink, W., Vermetten, E., & Schoevers, R. A. (2022) · Journal of Psychopharmacology

Psychedelics and Drug StudiesSchizophrenia research and treatment

Cited by 178

Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review

Schimmers, N., Breeksema, J. J., Smith-Apeldoorn, S. Y., Veraart, J., van den Brink, W., & Schoevers, R. A. (2022) · Psychopharmacology

Psychedelics and Drug StudiesReligion, Spirituality, and Psychology

Cited by 162

Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study

Breeksema, J. J., Niemeijer, A., Krediet, E., Karsten, T., Kamphuis, J., Vermetten, E., van den Brink, W., & Schoevers, R. (2024) · Scientific Reports

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 58